Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 118622
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118622
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.118622
Figure 5 Changes in serum liver function, renal function, and creatine kinase level in the patient.
A: The patient’s serum aspartate transaminase, alanine aminotransferase, γ-glutamyl transferase, and alkaline phosphatase levels; B: The patient’s serum direct bilirubin, indirect bilirubin, and total bilirubin levels; C: The patient’s serum uric acid level; D: The patient’s serum creatine kinase level. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: γ-glutamyl transpeptidase; DBIL: Direct bilirubin; IBIL: Indirect bilirubin; TBIL: Total bilirubin CK: Creatine kinase; UA: Uric acid.
- Citation: Jiang ZY, Liu RQ, Tang MJ, Fan HD, Yang WJ, Gong L, Mi XX, Shi JP. Early-onset hepatic fibrosis linking to a novel PYROXD2 mutation: A case report. World J Hepatol 2026; 18(5): 118622
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/118622.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.118622